The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
Conrad En Zuo Chan(DSO National Laboratories), Brendon J. Hanson(Waseda Bioscience Research Institute in Singapore)
Cited by 106
Related Papers
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine
|Scientific Reports|2018|40